Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethics as Epistemology: Rethinking Research on Children and Families through Care, Reflexivity, and Relational Practice.

Integrative psychological & behavioral science·2026
Same author

Correction to: Position Statement of the Indian Academy of Medical Genetics on Next Generation Sequencing-Based Testing for Rare Genetic Disorders.

Indian journal of pediatrics·2026
Same author

Organic Acidemias in India: Clinical and Molecular Spectrum.

Indian journal of pediatrics·2026
Same author

Biofilm Formation on Different Fabrics in the Presence of Sweat.

Indian journal of microbiology·2026
Same author

Position Statement of the Indian Academy of Medical Genetics on Next Generation Sequencing-Based Testing for Rare Genetic Disorders.

Indian journal of pediatrics·2026
Same author

Gynecologic Concerns for Children and Adolescents with Vascular Anomalies.

Journal of pediatric and adolescent gynecology·2026

Related Experiment Video

Updated: Jun 27, 2026

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma
09:10

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma

Published on: November 15, 2024

Insurance Hurdles for Laser Authorization in Pediatric Patients.

Deepti Gupta1

  • 1Division of Dermatology, Department of Pediatrics, Seattle Children's Hospital/University of Washington School of Medicine, 4800 Sandpoint Way NE, Seattle, WA 98105, USA.

Pediatric Clinics of North America
|June 25, 2026
PubMed
Summary

Pediatric laser procedures are safe and effective but often denied by insurers. Lack of evidence and coding issues contribute to inconsistent insurance coverage for these vital medical treatments.

Keywords:
CoverageInsuranceLaserMedical necessityPediatricPrior authorization

More Related Videos

CO2-Lasertonsillotomy Under Local Anesthesia in Adults
05:07

CO2-Lasertonsillotomy Under Local Anesthesia in Adults

Published on: November 6, 2019

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

Related Experiment Videos

Last Updated: Jun 27, 2026

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma
09:10

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma

Published on: November 15, 2024

CO2-Lasertonsillotomy Under Local Anesthesia in Adults
05:07

CO2-Lasertonsillotomy Under Local Anesthesia in Adults

Published on: November 6, 2019

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
04:43

Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

Published on: May 23, 2025

Area of Science:

  • Medical procedures
  • Pediatric medicine
  • Health insurance

Background:

  • Laser procedures demonstrate safety and efficacy in treating pediatric medical conditions.
  • Current insurance practices often classify these treatments as elective or cosmetic, leading to denials.
  • A perceived lack of robust evidence contributes to laser therapy being deemed experimental or investigational.

Purpose of the Study:

  • To analyze the challenges and inconsistencies in insurance coverage for laser procedures in pediatric patients.
  • To highlight the impact of evidence quality and coding on insurance claim approvals.
  • To underscore the need for improved understanding and coverage policies for pediatric laser therapies.

Main Methods:

  • Review of current literature on laser procedures in pediatric medicine.
  • Analysis of insurance denial trends and reasons for pediatric laser treatments.
  • Examination of coding practices, including the use of unlisted procedure codes.

Main Results:

  • Insurance coverage for pediatric laser procedures is highly inconsistent.
  • Denials often stem from classification as non-medically necessary or investigational.
  • Lack of specific Current Procedural Terminology (CPT) codes complicates billing and increases prior authorization requests.

Conclusions:

  • Inconsistent insurance coverage poses a significant barrier to accessing essential laser treatments for children.
  • Standardized coding and clearer evidence guidelines are needed to improve insurance approval rates.
  • Addressing these issues is crucial for ensuring pediatric patients receive timely and necessary medical care.